S 2042 · 110th Congress 2007โ€“2009, ended

SMA Treatment Acceleration Act

Latest action · Sep 12, 2007 Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Progress

Where this bill reached, and when. A stage with no date was not reached; one that failed a vote and later carried shows the date it carried.

  1. IntroducedSep 12, 2007
  2. Passed SenateNot reached
  3. Passed HouseNot reached
  4. To the PresidentNot reached
  5. Became lawNot reached

Summary

SMA Treatment Acceleration Act - Requires the Director of the National Institutes of Health (NIH) to upgrade and unify existing spinal muscular atrophy (SMA) clinical trial sites to establish a national clinical trials network for SMA. Requires the Director of NIH to ensure that such network: (1) conducts coordinated, multisite, clinical trials of pharmacological approaches to the treatment of SMA; and (2) rapidly and effectively disseminates scientific findings to the field.

Requires the Director of NIH to: (1) establish an SMA data coordinating center; and (2) expand and intensify NIH programs with respect to preclinical translation research and medicinal chemistry related to SMA.

Requires the Secretary of Health and Human Services, acting through the Director of the Centers for Disease Control and Prevention (CDC), to enhance and provide ongoing support to the existing SMA patient registry to provide for expanded research on the epidemiology of SMA. Directs the Secretary to ensure the collection and analysis of longitudinal data related to individuals of all ages with SMA.

Requires the Secretary to establish the Spinal Muscular Atrophy Coordinating Committee to: (1) coordinate activities across NIH and with other federal health programs and activities relating to SMA; and (2) conduct a study to identify barriers to the development of drugs for treating SMA and similar genetic disorders.

Requires the Director of NIH to establish a trans-National Institutes of Health cooperative research initiative on SMA to ensure the success of the SMA projects led by the National Institute of Neurological Disorders and Stroke.

Requires the Secretary to submit recommendations to Congress to improve and expand on incentives provided under the Orphan Drug Act and related statutes to promote SMA drug development.

Cosponsors 21

Members who signed on, in the order they did. Signatures ran from Sep 12, 2007 to Jul 31, 2008; 3 are original cosponsors, there from the day it was introduced.

SeatCosponsorSigned on
R-VAJohn WarnerOriginalSep 12, 2007
R-GAJohnny IsaksonOriginalSep 12, 2007
D-RISheldon WhitehouseOriginalSep 12, 2007
R-GASaxby ChamblissOct 18, 2007
D-WAMaria CantwellOct 22, 2007
D-OHSherrod BrownDec 3, 2007
D-NJFrank R. LautenbergDec 10, 2007
D-VAJim WebbDec 11, 2007
D-RIJack ReedDec 14, 2007
D-WAPatty MurrayDec 19, 2007
D-NMJeff BingamanFeb 11, 2008
D-CABarbara BoxerApr 1, 2008
D-CADianne FeinsteinApr 3, 2008
D-NJRobert MenendezJun 3, 2008
D-MAJohn F. KerryJun 12, 2008
I-VTBernard SandersJun 23, 2008
I-CTJoseph I. LiebermanJun 24, 2008
D-PARobert P. Casey Jr.Jul 14, 2008
D-NYHillary Rodham ClintonJul 17, 2008
D-ILBarack ObamaJul 23, 2008
D-MDBarbara A. MikulskiJul 31, 2008

Committees 1

Where it was sent and what each committee and subcommittee did with it, in order.

ChamberCommitteeWhat it did
SenateHealth, Education, Labor, and Pensions Committee
Referred Sep 12, 2007

Actions 3

Everything that happened, newest first.

  1. Sep 12, 2007Introduced in Senate
  2. Sep 12, 2007Sponsor introductory remarks on measure. (CR S11510-11511)
  3. Sep 12, 2007Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

In the Congressional Record 1

Days the Record’s own index lists this bill, newest first, with the pages and the members it names. Pages starting H are the House, S the Senate, E Extensions of Remarks.

WhereIn the RecordMembersDate
SenateDebate and remarks S11510Debbie Stabenow D-MISep 12, 2007

Related bills 1

Companion bills and other measures the record links to this one.

BillTitleRelationshipLatest action
HR 3334SMA Treatment Acceleration ActRelated billAug 2, 2007

Titles 2

Every title it has carried, official and short, at each stage.

Official Title as Introduced
A bill to authorize the Secretary of Health and Human Services to conduct activities to rapidly advance treatments for spinal muscular atrophy, neuromuscular disease, and other pediatric diseases, and for other purposes.
Short Titles as Introduced
SMA Treatment Acceleration Act

Subjects

Assigned by the Library of Congress. Policy area: Health.

Text 1

Each version as it was printed, newest first.

  1. Sep 12, 2007Introduced in Senate

Support LegiList

This page is free, carries no paywall, and is built and maintained by one person. If the record here is useful to you, a few dollars keeps it going.

Processed by Stripe in a separate window. LegiList never sees card details.

Everything here is as published by Congress: the summary is the Congressional Research Service's, the action wording is the clerks', and the subjects are the Library of Congress's. How far it got is read from the actions themselves, taking the most recent one of each kind, so a bill that failed a vote and later passed is shown as having passed. Records come from this bill on Congress.gov and govinfo.gov; cost estimates are the Congressional Budget Office's, and the hearings are the printed hearings GovInfo publishes, which can appear months after the hearing.